doi: 10.3389/fped.2014.00066 Received 09 May 2014 Accepted 09 June 2014 Published 27 June 2014 Volume 2 - 2014 Edited by Roberto Canitano, University Hospital of Siena, Italy Reviewed by Andrew Walter Zimmerman, Harvard Medical School, USA
Our goal is to help our patients achieve optimal health and improve their quality of life through personalized care
This is partially mediated by weight loss (less body mass means less cardiovascular work) and partially by direct metabolic effects
Europe By Indication By Dosage Strength By Distribution Channel By Patient Type Market Attractiveness Analysis By Country By Indication By Dosage Strength By Distribution Channel By Patient Type Key Takeaways East Asia Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country Historical Market Size Value (USD Billion) & Volume (Million Doses) Trend Analysis By Market Taxonomy, 2020 to 2024 Market Size Value (USD Billion) & Volume (Million Doses) Forecast By Market Taxonomy, 2025 to 2035 By Country China Japan South Korea By Indication By Dosage Strength By Distribution Channel By Patient Type Market Attractiveness Analysis By Country By Indication By Dosage Strength By Distribution Channel By Patient Type Key Takeaways South Asia & Pacific Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country Historical Market Size Value (USD Billion) & Volume (Million Doses) Trend Analysis By Market Taxonomy, 2020 to 2024 Market Size Value (USD Billion) & Volume (Million Doses) Forecast By Market Taxonomy, 2025 to 2035 By Country India Australia & New Zealand ASEAN Rest of SAP By Indication By Dosage Strength By Distribution Channel By Patient Type Market Attractiveness Analysis By Country By Indication By Dosage Strength By Distribution Channel By Patient Type Key Takeaways Middle East and Africa Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country Historical Market Size Value (USD Billion) & Volume (Million Doses) Trend Analysis By Market Taxonomy, 2020 to 2024 Market Size Value (USD Billion) & Volume (Million Doses) Forecast By Market Taxonomy, 2025 to 2035 By Country GCC Countries Northern Africa South Africa Turkiye Rest of MEA By Indication By Dosage Strength By Distribution Channel By Patient Type Market Attractiveness Analysis By Country By Indication By Dosage Strength By Distribution Channel By Patient Type Key Takeaways Key Countries Market Analysis USA Pricing Analysis Market Share Analysis, 2024 By Indication By Dosage Strength By Distribution Channel By Patient Type Canada Pricing Analysis Market Share Analysis, 2024 By Indication By Dosage Strength By Distribution Channel By Patient Type Brazil Pricing Analysis Market Share Analysis, 2024 By Indication By Dosage Strength By Distribution Channel By Patient Type Mexico Pricing Analysis Market Share Analysis, 2024 By Indication By Dosage Strength By Distribution Channel By Patient Type Argentina Pricing Analysis Market Share Analysis, 2024 By Indication By Dosage Strength By Distribution Channel By Patient Type Market Structure Analysis Competition Dashboard Competition Benchmarking Market Share Analysis of Top Players By Regional By Indication By Dosage Strength By Distribution Channel By Patient Type Competition Analysis Competition Deep Dive Novo Nordisk Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Eli Lilly Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Sanofi Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy AstraZeneca Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Jiangsu Hansoh Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Biocon Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Dr
